# Ginsenoside F1 **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/ginsenoside-f1 **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-28 **Evidence Score:** 2 / 10 **Category:** Compound **Also Known As:** Ginsenoside F₁, Ginseng saponin F1, Dammarane-type saponin F1, Deglycosylated ginsenoside Rg1, Panax saponin F1, GF1, Ginsenoside F-1 ## Overview Ginsenoside F1 is a rare triterpenoid saponin found in ginseng that exhibits [anti-inflammatory](/ingredients/condition/inflammation) activity by inhibiting p38 MAPK signaling pathways. This compound demonstrates [antioxidant](/ingredients/condition/antioxidant) properties and potential [anti-aging](/ingredients/condition/longevity) effects through modulation of cellular [stress response](/ingredients/condition/stress)s. ## Health Benefits • Exhibits potential [anti-inflammatory](/ingredients/condition/inflammation) effects through inhibition of p38 MAPK via molecular docking studies, although this is based on in vitro predictions. • Shows [anti-aging](/ingredients/condition/longevity) properties as an active ingredient in ginseng, supported by in vitro evidence. • Demonstrates antioxidation effects, with support from molecular modeling studies. • Predicted to be non-toxic based on ADMET profiling, indicating a favorable safety profile. • Likely drug-like properties as per Lipinski’s rule of five, although human trials are lacking. ## Mechanism of Action Ginsenoside F1 exerts [anti-inflammatory](/ingredients/condition/inflammation) effects by selectively inhibiting the p38 mitogen-activated protein kinase (p38 MAPK) signaling pathway, as demonstrated through molecular docking studies. The compound also provides antioxidant protection by scavenging [reactive oxygen species](/ingredients/condition/antioxidant) and reducing oxidative stress markers in cellular systems. These mechanisms contribute to its [anti-aging](/ingredients/condition/longevity) properties through preservation of cellular integrity and function. ## Clinical Summary Current evidence for ginsenoside F1 is primarily limited to in vitro studies and molecular docking predictions. Laboratory studies have shown promising [anti-inflammatory](/ingredients/condition/inflammation) activity through p38 MAPK inhibition, though human clinical trials are lacking. The [antioxidant](/ingredients/condition/antioxidant) and [anti-aging](/ingredients/condition/longevity) effects have been demonstrated in cell culture models but require validation in animal studies and human subjects. The evidence strength remains preliminary and requires further clinical investigation to establish therapeutic efficacy. ## Nutritional Profile Ginsenoside F1 is a bioactive triterpenoid saponin compound (not a macronutrient source) with the molecular formula C42H72O13 and a molecular weight of approximately 784.01 g/mol. It is a protopanaxatriol (PPT)-type ginsenoside, classified as a minor ginsenoside derived from the metabolic conversion of major ginsenoside Rg1 via hydrolysis of its sugar moiety. It contains no meaningful caloric, protein, fat, fiber, vitamin, or mineral content as an isolated compound. As a bioactive molecule, its relevant 'profile' centers on its phytochemical nature: it possesses a dammarane-type steroidal backbone with hydroxyl groups at C-3, C-6, C-12, and C-20 positions, and a single glucopyranose sugar unit attached at C-20. Concentrations in whole Panax ginseng root are trace-level, typically in the range of 0.001–0.05% dry weight, varying by species, plant age, and processing method. Bioavailability as an isolated compound is limited by poor aqueous solubility (logP estimated ~2.5–3.5), though its smaller sugar chain compared to major ginsenosides (e.g., Rg1) may confer relatively improved [intestinal permeability](/ingredients/condition/gut-health). ADMET predictions suggest moderate oral absorption with potential for passive diffusion across cell membranes. No established dietary reference intake or recommended dose exists; research doses in in vitro studies typically range from 1–100 μM. ## Dosage & Preparation No clinically studied dosage ranges are available due to the absence of human trials. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Safety data for isolated ginsenoside F1 is limited due to its recent identification and study. As a ginseng-derived compound, it may share similar contraindications with ginseng, including potential interactions with anticoagulant medications and blood sugar-lowering drugs. Pregnant and nursing women should avoid supplementation due to insufficient safety data. Individuals with hormone-sensitive conditions should consult healthcare providers before use, as ginsenosides may have estrogenic activity. ## Scientific Research The research dossier does not report any human clinical trials, RCTs, or meta-analyses for ginsenoside F1. Evidence is limited to computational modeling and in vitro predictions without specific PubMed PMIDs. ## Historical & Cultural Context There is no specific traditional or historical use detailed for ginsenoside F1 itself, although it is derived from Panax ginseng, which is utilized in various traditional medicine systems. ## Synergistic Combinations Panax ginseng, Rhodiola rosea, Ashwagandha, Turmeric, Green tea extract ## Frequently Asked Questions ### What foods contain ginsenoside F1 naturally? Ginsenoside F1 is found primarily in Asian ginseng (Panax ginseng) root, with higher concentrations in aged or fermented ginseng products. It occurs in much smaller amounts compared to major ginsenosides like Rb1 and Rg1. ### How much ginsenoside F1 should I take daily? No established dosage exists for isolated ginsenoside F1 due to limited clinical research. Most studies use ginseng extracts containing 0.1-2% total ginsenosides, with F1 representing a minor fraction of this amount. ### Does ginsenoside F1 help with inflammation better than other ginsenosides? Molecular docking studies suggest ginsenoside F1 may have selective p38 MAPK inhibitory activity, but comparative studies with other ginsenosides are lacking. More research is needed to determine its relative anti-inflammatory potency. ### Can ginsenoside F1 interact with blood pressure medications? While specific interactions with ginsenoside F1 are unknown, ginseng compounds may affect blood pressure and interact with cardiovascular medications. Patients taking blood pressure drugs should consult their physician before supplementation. ### Is ginsenoside F1 the same as other numbered ginsenosides? No, ginsenoside F1 has a distinct chemical structure from other ginsenosides like Rb1, Rg1, or Rd. Each ginsenoside has different molecular arrangements and potentially different biological activities and potencies. ### What does the research quality show about ginsenoside F1's anti-inflammatory claims? Most evidence for ginsenoside F1's anti-inflammatory effects comes from in vitro studies and molecular docking predictions, which suggest it may inhibit p38 MAPK signaling. While these laboratory findings are promising, human clinical trials are limited, meaning the real-world efficacy in people remains to be established. Current research supports further investigation but does not yet confirm therapeutic benefit in humans. ### Is ginsenoside F1 safe for long-term supplementation based on toxicity data? ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) profiling studies predict that ginsenoside F1 is non-toxic, which is encouraging for safety. However, these are computational predictions rather than comprehensive human safety trials, so long-term supplementation data in humans is still limited. Anyone considering sustained use should consult a healthcare provider, especially if taking other medications or supplements. ### How does ginsenoside F1's bioavailability compare to other ginsenoside forms? Ginsenoside F1 is a metabolite or derivative form that may have different absorption and bioavailability profiles compared to parent ginsenosides like Rb1 or Rg1, though direct comparative studies are sparse. Its ability to be absorbed and utilized by the body depends on factors like gut microbiota metabolism and formulation type. Research specifically examining ginsenoside F1 bioavailability in humans would help clarify whether it is absorbed more or less effectively than other ginsenoside types. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*